Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration

BACKGROUND: Renal impairment is a common complication of multiple myeloma. Cystatin-C is considered an accurate marker of glomerular filtration rate in several renal disorders. Microarray analysis has revealed that cystatin-C is one of the most highly up-regulated genes in multiple myeloma. The aim...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Terpos, Evangelos, Katodritou, Eirini, Tsiftsakis, Evangelos, Kastritis, Efstathios, Christoulas, Dimitrios, Pouli, Anastasia, Michalis, Eurydiki, Verrou, Evgenia, Anargyrou, Konstantinos, Tsionos, Konstantinos, Dimopoulos, Meletios A., Zervas, Konstantinos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Ferrata Storti Foundation 2009
Konular:
Multiple Myeloma
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2649362/
https://ncbi.nlm.nih.gov/pubmed/19252175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2008.000638
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller